Healthcare Financial News

Mint.This marks a shift from its first fund, when the firm largely stayed away from the sector due to concerns around balance sheets and asset quality. With credit cycles stabilizing after the post-pandemic stress, it now sees renewed opportunity across lending, wealth management and technology-led financial services.“We want to also now spend a lot more time on banking and financial services.

In the last few years, conversations on artificial intelligence (AI) have made their way from a few company boardrooms and R&D divisions to almost every company’s strategic vision and every investor’s daily life. There is hardly any seminar or conference—be it on healthcare, travel, consumer experience, legal affairs or economics—that doesn’t discuss the AI-led revolution. It is time to assess its impact on India, the world’s fastest-growing major economy.

retirement strategy. Over the past few years, she has focused on consolidating real estate holdings, increasing liquid investments through mutual funds, and creating multiple income streams, such as rental income, to ensure financial stability and healthcare security in retirement.For Ahmedabad-based Vijay Vora, a chartered accountant, 75, who is currently self-employed as a management adviser and corporate consultant, retirement income comes from a mix of rental income from real estate, interest from fixed deposits, Public Provident Fund (PPF) savings, dividends, and freelancing income.Going ahead, he wants to start systematic withdrawal plans from his mutual funds.

Mint.“The acquisition was strategic in nature for us and they bring their partnerships on the procurement side of running warehouse management and the serviceability of an order that is coming from rural India," said Mohapatra.While the company declined to comment on the financial details of the transaction, it said that it had not raised additional funding to finance the acquisition and that it was done through the company's existing funds.The acquisition brings Saveo's 10,000 platform partners across Karnataka, Telangana, Andhra Pradesh and Tamil Nadu into CureBay's network of 190 clinics.Most of the integrations of Saveo's pharma distribution business into CureBay have already been completed. “In a few of our markets, we are already hitting the market with the combined power of both the organizations and talent," said Mohapatra.India's rural healthcare market is fragmented with multiple models, including remote patient monitoring, mobile hospitals and more.

SaaS players that are rapidly adding AI-powered products. Startups must build technology that can’t easily be replaced by large language models while also generating revenue and scaling.“There’s the SaaS and software companies that are building on top of AI models and launching agentic solutions to their customers.

Pet parenting in India is harder than it should be.” Vineet Khanna, co-founder of pet support platform Supertails, leans back in his chair and gives two examples that illustrate the lack of an ecosystem and low awareness about pets and pet parenting that make it so difficult.Two girls tele-consulted the Supertails vet, saying their newly acquired cat was making “a strange sound”. The call switched to video, but the cat, unaware of the attention, took some time before she made the mysterious sounds that had her minders worried.

private equity firms adopt a more cautious approach amid geopolitical tensions and tighter exit conditions. Private equity and venture capital firms raised a record $23.2 billion across 123 India-focused funds in 2025, underscoring sustained investor appetite.The firm has already begun deploying capital from the new fund, writing cheques in the range of $15–25 million, and is actively scouting deals in financial services, healthcare, manufacturing and consumer sectors, the people added.Emails sent to OIJIF on Thursday remained unanswered till press time.Established in 2011, the firm has invested over $330 million across 19 companies through its first two funds.

Aster DM Healthcare India Ltd has secured approval from its shareholders and unsecured trade creditors for its amalgamation with Blackstone-backed Quality Care India Ltd more than a year after the deal was announced.The voting was held on 10 March, and the results were declared on 11 March. The deal was announced in November 2024.The merger was approved by 96.68% of shareholders and all unsecured creditors, stock exchange notifications from Wednesday showed.Aster's deputy managing director Alisha Moopen told Mint that the merger is expected to be completed in the first quarter of fiscal 2027.Aster and Quality will merge via a share-swap ratio of 977 shares of Aster for every 1,000 shares of QCIL.Aster shareholders will hold 57.3% and QCIL shareholders 42.7% in the merged entity — Aster DM Quality Care, which will be the new name for current listed entity Aster DM Healthcare.Blackstone will be the largest shareholder in the merged entity with 30.7% shareholding, followed by Aster’s promoters (the Moopens, 24%).

Stock market recap: Indian equity markets faced severe downward pressure on Wednesday, as benchmark indices erased the previous session’s gains to end sharply lower. Nifty 50 plunged 1.63% to settle at 23,866.85, slipping below the psychological 24,000 mark, while S&P BSE Sensex tanked 1,342.27 points or 1.72% to close at 76,863.71.Sentiment was rattled by escalating geopolitical tensions in West Asia, which sent Brent crude prices surging above $91 per barrel, fueling inflation fears.Domestic headwinds, including a weakening rupee, which touched 92.04 per dollar, and relentless FII outflows exceeding ₹32,800 crore this month, further dampened investor confidence.

Last week, I wrote about how frontier artificial intelligence (AI) has begun to improve exponentially—to the point where it is not just introducing linear improvements in functionality, but literally augmenting capabilities. Personally, this became evident when I realized I could code anything I could imagine, allowing me to create various applications and programs to eliminate micro-frustrations in my workflow. I am sure that those in other domains are experiencing similar capability uplifts.

For many urban women, egg freezing is increasingly becoming part of long-term life planning, much like buying insurance or investing for retirement. But unlike most financial goals, this one comes with a biological deadline, and it isn’t cheap.The procedure typically costs ₹1.35- ₹3 lakh per cycle, with annual storage fees of ₹10,000–30,000 and potential IVF expenses later.

Bengaluru: Varun Dubey, who has spent the past decade moving between India’s consumer internet and healthcare worlds, now wants to build what he calls an “honest healthcare” hospital system—starting with a membership pass that covers consultations and doctor-prescribed diagnostics for a family.“The customer has three fundamental problems when it comes to core healthcare experience today…i.e. high quality care, seamless and easy to access as possible and of course, affordable,” Dubey said in an interview.Dubey’s argument is that India’s hospital experience today is broken due to crowded outpatient departments (OPDs), long waits, opaque billing and low trust arising from one underlying issue: the cost of setting up and running a hospital.That mismatch between what patients want and how hospitals are run, Dubey says, is why he is building SuperHealth.Launched in October, SuperHealth is positioning itself not as an OPD app but as a full hospital, trying to win patients on experience and trust—less wait times, clearer pricing, and fewer incentives for doctors to overprescribe.

Mumbai: Umesh Modi Group’s Win-Medicare Pvt Ltd (WMPL), the maker of household brands like Betadine and Movicol, is looking to sell a minority stake in a deal valued between $150 million and $200 million, according to three sources familiar with the matter. The company has appointed EY as its advisor to lead the search for potential buyers, they said.“About $100 million is likely to be secondary, with the parent entity expected to offload a minority stake, while the remaining component would be primary but subject to the company’s expansion plans,” two of the people cited above said on the condition of anonymity.The third person said, “The deal was launched about two months ago and several private equity firms have been tapped as part of the process.

aviation and maritime corridors that connect India with key West Asian markets, complicating travel planning for patients and increasing freight expenses for exporters.While companies have yet to report a sustained demand shock, hospitals and drugmakers say the disruption to mobility and logistics systems underpinning cross-border healthcare and medicine trade raises the risk of softer medical travel volumes and higher export costs if tensions persist.The aviation disruption is particularly significant for India’s medical tourism sector, which recorded approximately 644,387 foreign tourist arrivals in 2024. It is particularly exposed to West Asia, a region that accounts for nearly 18% of inbound patients, or about 115,000 travellers, seeking treatment ranging from complex surgeries to advanced clinical care.As regional airspace comes under heightened security scrutiny, industry leaders say travel uncertainty is beginning to influence patient decision-making.

Mint.Developed by the Centre for Development of Advanced Computing (CDAC), the SaaS-based digital platform—eSushrut@Clinic—is a "Lite" alternative to the often bulky and expensive hospital information management systems (HIMS) currently in the market, and is aimed at bridging digital divide in Indian healthcare, the two officials cited earlier said on the condition of anonymity.With comparisons being drawn to BHIM (Bharat Interface for Money) UPI (Unified Payments Interface), one of the most useful features is the built-in “Smart Assistant”. Its Clinical Decision Support System (CDSS) helps doctors manage chronic conditions by offering clear, evidence-based treatment guidance.“The platform allows doctors to digitize records and streamline consultations, improving care continuity without replacing human expertise,” said the first of the two officials cited earlier.The new e-platform serves as a government-backed, reliable entry point for small-scale doctors to join the national digital health ecosystem, much like what the BHIM app did for digital payments.

healthcare access, and household finances months after their exit from the company.However, employees noted that the CEO, Ankur Jain, was not at his residence during the demonstration.The group has also launched an Instagram page documenting employee grievances and the protest.The protest underscores the severity of the financial and governance crisis at B9 Beverages, once among India’s fastest-growing craft brewers. What began as delayed salary payments in late 2024 escalated into halted production, large-scale exits and mounting statutory disputes—raising broader questions around startup governance, employee protections, and accountability in venture-backed firms.Employees said repeated attempts to seek clarity on repayment timelines failed to yield firm commitments, prompting the decision to protest outside the promoter’s residence.“There is no other place for us to protest, except outside his house,” one employee said.Jain expressed regret over unpaid salaries.

Stock market recap: Benchmark domestic indices, the Sensex and the Nifty 50, ended lacklustre on Thursday, 26 February, due to profit booking in select heavyweights, including HDFC Bank and Axis Bank, amid mixed global cues.The Sensex ended 27 points, or 0.03%, lower at 82,248.61, while the Nifty 50 inched up by 14 points, or 0.06%, to settle at 25,496.55.The mid and small-cap segments ended with gains; the BSE 150 MidCap Index clocked a decent gain of 0.55%, while the BSE 250 SmallCap Index rose by 0.07%.The overall market capitalisation of BSE-listed firms increased to ₹468 trillion from ₹467 trillion n the previous session.Two stock recommendations by MarketSmith India:Buy: Fortis Healthcare Ltd(current price: ₹963.65)Buy: Mankind Pharma Ltd (current price: ₹2,280)Nifty 50 performance | 26 FebruaryIndian equities ended on a subdued note on February 26th, with Nifty 50 closing at 25,496.55, up 14.05 points or 0.06%, after oscillating between 25,400.95 and 25,572.95 during the session. The index witnessed intraday volatility but staged a late recovery, indicating buying interest near 25,400, while 25,600 continues to act as an immediate resistance.

retirement savings with immediate healthcare liquidity.The NPS Swasthya Equity Plus scheme follows a high-growth investment mandate to counter medical inflation.Subscribers can withdraw up to 25% of their own contributions for medical expenses, including OPD, diagnostics and pharmacy purchases. However, the first withdrawal is permitted only after the account accumulates at least ₹50,000.

Mint.The growth ambition comes as India’s premium personal care and wellness market intensifies, drawing aggressive FMCG majors, venture-backed startups and global brands. Cipla Health is betting that its pharmaceutical lineage and scientific credibility can help it scale brands into large consumer franchises.“We don't have as many large consumer health brands in India at the moment,” Puri said.

Subscribe to enjoy similar stories. On 14 February, the boards of Religare Enterprises Ltd (REL) and Religare Finvest Ltd (RFL) approved a demerger of its insurance and financial services businesses into two separate listed entities. REL will retain control of Care Health Insurance, while lending, broking, investment, and ancillary activities would be transferred to RFL.

cement division in 2023 after 12 years at BCG. In 2024, Abhishek Malhotra, who has worked at McKinsey and Kearneyover 10 years, joined RPSG Group as president and strategy head.